Free CME-Accredited Program | 3 Activities | 3 CME Credits
Ulcerative colitis (UC) is a lifelong, complex condition that requires more than a one-size-fits-all approach. Variations in disease severity, age, treatment response, comorbidities, and life stage make personalized treatment essential for better long-term outcomes.
Ulcerative Colitis Care: Personalized Treatment Pathways is a free, CME-accredited program that helps healthcare professionals apply the latest science to patient-centered care. Through expert discussions, real-world cases, and interactive learning, it equips clinicians to make confident, individualized treatment decisions across the UC spectrum.
What This Program Offers
Three On-Demand Learning Activities
1 CME Credit per Activity (3 CME Credits Total)
Case-Based and Evidence-Driven Content
Flexible Learning for Busy HCPs
Faculty
Dr. Ayal Hirsch
Prof. Uri Kopylov
Director of an IBD clinic with extensive research in IBD and endoscopy, author of over 260 peer-reviewed publications. Serves as secretary of the Israeli IBD Society and on the European Crohn’s and Colitis Organization Educational Committee. Co-directs Sheba ARC’s Innovation Center in Gastroenterology, focusing on IP-driven innovation.
Advancing Care: Breakthroughs in Diagnosing and Treating Ulcerative Colitis
On-Demand Expert-Led Webinar | 1 CME Credit
This in-depth webinar reviews the latest advances in UC diagnosis and management, connecting disease mechanisms to emerging therapeutic strategies. Expert presentations explore disease pathophysiology, patient burden, and the evolving role of personalized medicine.
Dr. Ayal Hirsch examines the underlying causes of UC and highlights emerging treatments, including IL-23 inhibitors, JAK inhibitors, and S1P receptor modulators. Prof. Uri Kopylov addresses real-world clinical challenges such as steroid overuse, suboptimal disease control, and unmet patient needs, offering practical guidance for daily practice.
Learning Objectives
- Understand UC pathophysiology, symptoms, and complications, with emphasis on younger patients
- Explore advances in UC management, including biologics, S1P receptor modulators, and JAK inhibitors
- Integrate pharmacological and lifestyle interventions into patient-centered care and communication
Personalized Treatment Plans for Ulcerative Colitis
On-Demand Case-Based Workshop | 1 CME Credit
How do you individualize therapy when UC patients present with competing clinical priorities? This interactive workshop explores personalized treatment approaches through three complex patient cases, highlighting how real-world variables influence therapeutic decision-making.
Through guided discussion, learners examine how factors such as age, disease severity, prior treatment response, growth delay, and reproductive planning shape the selection and timing of advanced therapies.
Learning Objectives
- Critically evaluate treatment strategies in complex UC cases, including the use of advanced therapies
- Strengthen shared decision-making to align treatment plans with individual patient goals
- Identify multidisciplinary care strategies to support improved long-term outcomes
Ulcerative Colitis Treatment Innovations: A Microlearning Series
Interactive · Case-Based · On-Demand | 1 CME Credit
Designed for clinicians on the move, this 60-minute interactive microlearning series delivers focused, high-impact education across three concise modules. Each 20-minute session combines expert insight with real-life scenarios to reinforce clinical application.
What You’ll Gain
- Deeper understanding of emerging UC therapies, including S1P receptor modulators and JAK inhibitors
- Practical strategies for personalized UC management in adults and adolescents
- Case-based learning to strengthen clinical decision-making
Module Overview
- S1P Receptor Modulators in UC
- Clinical Management with Oral Small Molecules
- Special Considerations for Adolescents and Isolated Proctitis
Gastroenterologist in Chicago, Illinois, with expertise in Viral Gastroenteritis, Crohn’s Disease, Hemorrhagic Proctocolitis, Colonoscopy, and Endoscopy. He has co-authored 32 peer-reviewed articles and 29 on Viral Gastroenteritis.